Nothing Special   »   [go: up one dir, main page]

EA201400202A1 - Применение эстетрола в качестве экстренного контрацептива - Google Patents

Применение эстетрола в качестве экстренного контрацептива

Info

Publication number
EA201400202A1
EA201400202A1 EA201400202A EA201400202A EA201400202A1 EA 201400202 A1 EA201400202 A1 EA 201400202A1 EA 201400202 A EA201400202 A EA 201400202A EA 201400202 A EA201400202 A EA 201400202A EA 201400202 A1 EA201400202 A1 EA 201400202A1
Authority
EA
Eurasian Patent Office
Prior art keywords
emergency
esthetrol
contractive
application
present
Prior art date
Application number
EA201400202A
Other languages
English (en)
Other versions
EA028780B1 (ru
Inventor
Ваут Ваутерс
Герман Ян Теймен Кулинг-Беннинк
Людивин Пёти
Жан-Мишель Фуадар
Original Assignee
Эстетра С.П.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эстетра С.П.Р.Л. filed Critical Эстетра С.П.Р.Л.
Publication of EA201400202A1 publication Critical patent/EA201400202A1/ru
Publication of EA028780B1 publication Critical patent/EA028780B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Настоящее изобретение относится к новому применению тетрагидроксилированных эстрогенов, таких как эстетрол (1,3,5(10)-эстратриен-3,15α,16α,17β-тетрол), а именно к способу экстренной контрацепции. Способ экстренной контрацепции в соответствии с настоящим изобретением включает пероральное введение эстетрола в однократной дозе в пределах 120 ч от полового сношения.
EA201400202A 2011-08-11 2012-08-09 Применение эстетрола в качестве экстренного контрацептива EA028780B1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161522480P 2011-08-11 2011-08-11
EP11177266.1 2011-08-11
EP11177266 2011-08-11
US61/522,480 2011-08-11
PCT/EP2012/065572 WO2013021025A1 (en) 2011-08-11 2012-08-09 Use of estetrol as emergency contraceptive

Publications (2)

Publication Number Publication Date
EA201400202A1 true EA201400202A1 (ru) 2014-06-30
EA028780B1 EA028780B1 (ru) 2017-12-29

Family

ID=47667911

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400202A EA028780B1 (ru) 2011-08-11 2012-08-09 Применение эстетрола в качестве экстренного контрацептива

Country Status (20)

Country Link
US (3) US9579329B2 (ru)
EP (1) EP2741824B1 (ru)
AU (2) AU2012293593B2 (ru)
BR (1) BR112014003113A2 (ru)
CA (1) CA2843951C (ru)
CY (1) CY1118996T1 (ru)
DK (1) DK2741824T3 (ru)
EA (1) EA028780B1 (ru)
ES (1) ES2631359T3 (ru)
HK (1) HK1197027A1 (ru)
HR (1) HRP20170797T1 (ru)
HU (1) HUE033590T2 (ru)
LT (1) LT2741824T (ru)
ME (1) ME02723B (ru)
PL (1) PL2741824T3 (ru)
PT (1) PT2741824T (ru)
RS (1) RS55974B1 (ru)
SI (1) SI2741824T1 (ru)
SM (1) SMT201700310T1 (ru)
WO (1) WO2013021025A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE029252T2 (en) 2011-06-01 2017-02-28 Estetra Sprl Process for the preparation of intermediates of estetrol
SG195121A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
HUE033590T2 (hu) * 2011-08-11 2017-12-28 Estetra Sprl Esztetrol alkalmazása sürgõsségi fogamzásgátlóként
TW201613576A (en) 2014-06-26 2016-04-16 Novartis Ag Intermittent dosing of MDM2 inhibitor
PE20180398A1 (es) 2015-06-18 2018-02-28 Mithra Pharmaceuticals S A Unidad de dosificacion orodispersable que contiene un componente estetrol
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
US10888518B2 (en) * 2015-06-18 2021-01-12 Estetra Sprl Orodispersible tablet containing estetrol
SI3310333T1 (sl) 2015-06-18 2020-08-31 Estetra Sprl Orodisperzibilna enota odmerka, ki vsebuje komponento estetrola
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2297273A1 (en) * 2000-01-26 2001-07-26 Michael D. Perelgut 3 dimensional imaging of hard structure without the use of ionizing radiation
US7732430B2 (en) * 2001-05-23 2010-06-08 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception
CA2448273C (en) * 2001-05-23 2010-06-29 Christian Franz Holinka Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
HU227198B1 (en) * 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
CA2505190C (en) 2002-11-08 2012-07-10 Pantarhei Bioscience B.V. Synthesis of estetrol via estrone derived steroids
JP2004235111A (ja) * 2003-01-31 2004-08-19 Ebara Corp イオン伝導体及びその製造方法
HUE033590T2 (hu) * 2011-08-11 2017-12-28 Estetra Sprl Esztetrol alkalmazása sürgõsségi fogamzásgátlóként
HUE035848T2 (en) * 2013-12-12 2018-05-28 Donesta Bioscience B V Solid dispensing unit containing an estetrol compound in the mouth

Also Published As

Publication number Publication date
HUE033590T2 (hu) 2017-12-28
HK1197027A1 (en) 2015-01-02
BR112014003113A2 (pt) 2017-03-14
ES2631359T3 (es) 2017-08-30
ME02723B (me) 2017-10-20
EA028780B1 (ru) 2017-12-29
US9579329B2 (en) 2017-02-28
AU2012293593A1 (en) 2014-03-06
AU2017203991A1 (en) 2017-07-06
CA2843951C (en) 2019-08-06
US20210290636A1 (en) 2021-09-23
US20170196886A1 (en) 2017-07-13
PT2741824T (pt) 2017-07-06
HRP20170797T1 (hr) 2017-08-11
EP2741824A1 (en) 2014-06-18
CA2843951A1 (en) 2013-02-14
AU2017203991B2 (en) 2019-03-14
US20140200202A1 (en) 2014-07-17
LT2741824T (lt) 2017-06-26
SMT201700310T1 (it) 2017-07-18
PL2741824T3 (pl) 2018-03-30
CY1118996T1 (el) 2018-01-10
AU2012293593B2 (en) 2017-03-23
EP2741824B1 (en) 2017-05-03
WO2013021025A1 (en) 2013-02-14
DK2741824T3 (en) 2017-07-10
AU2012293593A8 (en) 2014-05-29
RS55974B1 (sr) 2017-09-29
SI2741824T1 (sl) 2017-06-30

Similar Documents

Publication Publication Date Title
EA201400202A1 (ru) Применение эстетрола в качестве экстренного контрацептива
CL2017000830A1 (es) Formulación estable que comprende un azúcar no reductora, un anticuerpo anti-s4b7 y al menos un aminoácido libre; un método para preparar dicha formulación; uso de dicha formulación para tratar una enfermedad inflamatoria del intestino.
DOP2014000085A (es) Derivados de (4-fenilimidazol-2-il)etilamina útiles como moduladores de canal de sodio
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
EA201490546A1 (ru) Замещенные аннелированные пиримидины и их применение
PE20151436A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
CR11455A (es) Compuestos nuevos de hidrocarbono ciclico para el tratamiento de enfermedades
EA201291372A1 (ru) Фармацевтическая композиция, содержащая дроспиренон, и набор для предупреждения зачатия
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
MY181159A (en) Sublingual and buccal film compositions
BR112012013487A2 (pt) Composições de amantadina e métodos de uso
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
NZ714684A (en) Stable oral solutions for combined api
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX2016009217A (es) Inmunoterapia basada en liposomas.
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
EA201691299A1 (ru) Применение лахинимода для замедления прогрессирования болезни хантингтона
AR089114A1 (es) PREVENCION DE LOS EFECTOS ADVERSOS CAUSADOS POR LOS ANTICUERPOS BIESPECIFICOS EpCAMxCD3
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
NZ622927A (en) Composition comprising scirpusin a and scirpusin b anti-obesity potential thereof
MX2013012038A (es) Combinacion de carotenoide, fitoestrogeno y vitamina c para la humectacion de la piel.
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
EA201590903A1 (ru) Применение и режим приема фармацевтической композиции, содержащей левоноргестрел и ингибитор цог, для контрацепции по мере необходимости ("on-demand")